ClinicalTrials.gov
public full text
Public Domain
HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy
The humanized monoclonal antibody against Lewis Y antigen (Hu3S193) has been demonstrated to be safe in previous studies and has also been indicated as potential intervention in breast cancer. The study of this new agent in advanced breast cancer may contribute to the development of new strategies for patients that progressed after hormonal treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Estrogens and breast cancer#1427833
- Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer#1440006
- An InDel genomic variant within a bifunctional super-enhancer for LINC00636 and CD47 regulation in breast cancer#1311847
- A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma#311172
- Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen#1296024
Record · ID 1464157
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive